Correction of Glycogen Storage Disease Type II by Enzyme Replacement with a Recombinant Human Acid Maltase Produced by Over-Expression in a CHO-DHFRneg Cell Line

This publication has 27 references indexed in Scilit:

• Recombinant Human Acid -Glucosidase: High Level Production in Mouse Milk, Biochemical Characteristics, Correction of Enzyme Deficiency in GSDII KO Mice
  Human Molecular Genetics, 1998
• Targeted Disruption of the Acid α-Glucosidase Gene in Mice Causes an Illness with Critical Features of Both Infantile and Adult Human Glycogen Storage Disease Type II
  Journal of Biological Chemistry, 1998
• Generalized glycogen storage and cardiomegaly in a knockout mouse model of Pompe disease
  Human Molecular Genetics, 1998
• Glycogenosis type II (acid maltase deficiency)
  Muscle & Nerve, 1995
• Sequence of the cDNA and 5′-Flanking Region for Human Acid α-Glucosidase, Detection of an Intron in the 5′ Untranslated Leader Sequence, Definition of 18-bp Polymorphisms, and Differences with Previous cDNA and Amino Acid Sequences
  DNA and Cell Biology, 1990
• Isolation of a cDNA for human acid alpha-glucosidase and detection of genetic heterogeneity for mRNA in three alpha-glucosidase-deficient patients.
  Proceedings of the National Academy of Sciences, 1986
• Trafficking of lysosomal enzymes in normal and disease states.
  Journal of Clinical Investigation, 1986
• Residual acid maltase activity in late‐onset acid maltase deficiency
  Neurology, 1977
• The spectrum and diagnosis of acid maltase deficiency
  Neurology, 1973
• α-Glucosidase deficiency in generalized glycogen-storage disease (Pompe's disease)
  Biochemical Journal, 1963